The assessment of non-feminizing estrogens for use in neuroprotection

Brain Research

Volumn 1379, Issue , 2011, Pages 61-70

  Yi, Kun Don ^a   Perez, Evelyn ^b   Yang, Shaohua ^a   Liu, Ran ^a   Covey, Douglas F ^c   Simpkins, James W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estradiol; Estratrienes; Estrogen; Estrogen receptor; Estrone; Middle cerebral artery occlusion; Neuroprotection; Phenolic A ring; Structure activity relationship

Indexed keywords

ANTIOXIDANT; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; NON FEMINIZING ESTROGEN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; BINDING AFFINITY; DRUG SCREENING; HUMAN; IN VITRO STUDY; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL DEATH; CELL SURVIVAL; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; NEUROPROTECTIVE AGENTS; RECEPTORS, ESTROGEN;

ANIMALIA;

EID: 79952317514     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.11.058     Document Type: Review

References (79)

1. Alkayed, N.J., Harukuni, I., Kimes, A.S., London, E.D., Traystman, R.J., Hurn, P.D., 1998. Gender-linked brain injury in experimental stroke. Stroke 29, 159-165 discussion 166.
2. Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C.J., Holsboer, F., 1997. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51, 535-541.
3. Bingham, D., Macrae, I.M., Carswell, H.V., 2005. Detrimental effects of 17β-oestradiol after permanent middle cerebral artery occulsion. J. Cereb. Blood Flow Metab. 25, 414-420.
4. Brinton, R.D., 2004. Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM. J. Alzheimers Dis. 6, S27-S35. (Pubitemid 40202539)
5. Cardounel, A., Regelson, W., Kalimi, M., 1999. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc. Soc. Exp. Biol. Med. 222, 145-149.
6. Carswell, H.V., Anderson, N.H., Morton, J.J., McCulloch, J., Dominiczak, A.F., Macrae, I.M., 2000a. Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult. J. Cereb. Blood Flow Metab. 20, 931-936.
7. Carswell, H.V., Dominiczak, A.F., Macrae, I.M., 2000b. Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 278, H290-H294.
8. Cervantes, M., Gonzalez-Vidal, M.D., Ruelas, R., Escobar, A., Morali, G., 2002. Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch. Med. Res. 33, 6-14.
9. Coker, L.H., Hogan, P.E., Bryan, N.R., Kuller, L.H., Margolis, K.L., Bettermann, K., Wallace, R.B., Lao, Z., Freeman, R., Stefanick, M.L., Shumaker, S.A., 2009. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology 72, 125-134.
10. Dicko, A., Morissette, M., Ben Ameur, S., Pezolet, M., Di Paolo, T., 1999. Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy. Brain Res. Bull. 49, 401-405.
11. Dubal, D.B., Kashon, M.L., Pettigrew, L.C., Ren, J.M., Finklestein, S.P., Rau, S.W., Wise, P.M., 1998. Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18, 1253-1258.
12. Dubal, D.B., Wise, P.M., 2001. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 142, 43-48. (Pubitemid 32183664)
13. Dubal, D.B., Zhu, H., Yu, J., Rau, S.W., Shughrue, P.J., Merchenthaler, I., Kindy, M.S., Wise, P.M., 2001. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl Acad. Sci. USA 98, 1952-1957.
14. Dubey, R.K., Imthurn, B., Barton, M., Jackson, E.K., 2005. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66, 295-306.
15. Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C., Newhouse, P., 2008. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm. Behav. 53, 159-169.
16. Fan, T., Perez, E.J., Eberst, K.L., Covey, D.F., Chen, H.X., Day, A.L., Simpkins, J.W., 2001. ZYC-13, the enantiomer of 1, 3, 5(10)-estratriene 3-ol, exerts neuroprotective effects in vitro and in vivo. Society for Neuroscience. Abstract A 27.
17. Finucane, F.F., Madans, J.H., Bush, T.L., Wolf, P.H., Kleinman, J.C., 1993. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch. Intern. Med. 153, 73-79.
18. Gelinas, S., Martinoli, M.G., 2002. Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells. J. Neurosci. Res. 70, 90-96.
19. Ghose, A.K., Crippen, G.M., 1987. Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions. J. Chem. Inf. Comput. Sci. 27, 21-35.
20. Gonzalez-Vidal, M.D., Cervera-Gaviria, M., Ruelas, R., Escobar, A., Morali, G., Cervantes, M., 1998. Progesterone: protective effects on the cat hippocampal neuronal damage due to acute global cerebral ischemia. Arch. Med. Res. 29, 117-124.
21. Goodman, Y., Bruce, A.J., Cheng, B., Mattson, M.P., 1996. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844. (Pubitemid 26118770)
22. Green, P.S., Gridley, K.E., Simpkins, J.W., 1996. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218, 165-168.
23. Green, P.S., Bishop, J., Simpkins, J.W., 1997a. 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17, 511-515. (Pubitemid 27024564)
24. Green, P.S., Gordon, K., Simpkins, J.W., 1997b. Phenolic A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 63, 229-235.
25. Green, P.S., Gridley, K.E., Simpkins, J.W., 1998. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 84, 7-10. (Pubitemid 28081520)
26. Green, P.S., Simpkins, J.W., 2000. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18, 347-358.
27. Green, P.S., Yang, S.H., Nilsson, K.R., Kumar, A.S., Covey, D.F., Simpkins, J.W., 2001. The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a ratmodel of cerebral ischemia. Endocrinology 142, 400-406. (Pubitemid 32183701)
28. Gridley, K.E., Green, P.S., Simpkins, J.W., 1997. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778, 158-165.
29. Gridley, K.E., Green, P.S., Simpkins, J.W., 1998. A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Mol. Pharmacol. 54, 874-880.
30. Grodstein, F.,Manson, J.E., Stampfer,M.J., 2006.Hormone therapy and coronary heart disease: the role of time sincemenopause and age at hormone initiation. J Womens Health (Larchmt). 15, 35-44.
31. Gursoy, E., Cardounel, A., Kalimi, M., 2001. Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. Neurochem. Res. 26, 15-21.
32. Hall, E.D., Pazara, K.E., Linseman, K.L., 1991. Sex differences in postischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 11, 292-298.
33. Harman, S.M., 2004. What do hormones have to do with aging? What does aging have to do with hormones? Ann. NY Acad. Sci. 1019, 299-308.
34. Harukuni, I., Hurn, P.D., Crain, B.J., 2001. Deleterious effect of 17β-estradiol in a rat model of transient forebrain ischemia. Brain Res. 900, 137-142. (Pubitemid 32452273)
35. Hodis, H.N., Mack, W.J., Lobo, R.A., 2003. Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease. Circulation 108, e5 author reply e5.
36. Ing, N.H., Ott, T.L., 1999. Estradiol up-regulates estrogen receptor-alphamessenger ribonucleic acid in sheep endometrium by increasing its stability. Biol. Reprod. 60, 134-139.
37. Jiang, N., Chopp, M., Stein, D., Feit, H., 1996. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 735, 101-107. (Pubitemid 26336624)
38. Kimonides, V.G., Khatibi, N.H., Svendsen, C.N., Sofroniew, M.V., Herbert, J., 1998. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl Acad. Sci. USA 95, 1852-1857.
39. Liang, Y., Belford, S., Tang, F., Prokai, L., Simpkins, J.W., Hughes, J.A., 2001. Membrane fluidity effects of estratrienes. Brain Res. Bull. 54, 661-668.
40. Liao, S., Chen, W., Kuo, J., Chen, C., 2001. Association of serum estrogen level and ischemic neuroprotection in female rats. Neurosci. Lett. 297, 159-162.
41. Liu, R., Yang, S.H., Perez, E., Yi, K.D., Wu, S.S., Eberst, K., Prokai, L., Prokai-Tatrai, K., Cai, Z.Y., Covey, D.F., Day, A.L., Simpkins, J.W., 2002. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke 33, 2485-2491.
42. Maki, P.M., 2006. Potential importance of early initiation of hormone therapy for cognitive benefit. Menopause 13, 6-7.
43. Manson, J.E., Allison, M.A., Rossouw, J.E., Carr, J.J., Langer, R.D., Hsia, J., Kuller, L.H., Cochrane, B.B., Hunt, J.R., Ludlam, S.E., Pettinger, M.B.,Gass,M.,Margolis,K.L.,Nathan, L.,Ockene, J.K.,Prentice,R.L., Robbins, J., Stefanick, M.L., 2007. Estrogen therapy and coronary-artery calcification. N. Engl. J. Med. 356, 2591-2602.
44. McCullough, L.D., Alkayed, N.J., Traystman, R.J., Williams, M.J., Hurn, P.D., 2001. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 32, 796-802.
45. Miller, C.P., Jirkovsky, I., Hayhurst, D.A., Adelman, S.J., 1996. In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61, 305-308.
46. Mooradian, A.D., 1993. Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45, 509-511.
47. Moosmann, B., Behl, C., 1999. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl Acad. Sci. USA 96, 8867-8872.
48. Paganini-Hill, A., Henderson, V.W., 1996. Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 156, 2213-2217.
49. Perez, E., Liu, R., Yang, S.H., Cai, Z.Y., Covey, D.F., Simpkins, J.W., 2005a. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res. 1038, 216-222. (Pubitemid 40332686)
50. Perez, E., Cai, Zu. Yun, Covey, Douglas F., Simpkins, James W., 2005b. Neuroprotective effects of estratriene analogs: structure-activity relationships and molecular optimization. Drug Dev. Res. 66, 78-92.
51. Prokai, L., Prokai-Tatrai, K., Perjesi, P., Zharikova, A.D., Perez, E.J., Liu, R., Simpkins, J.W., 2003a. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc. Natl Acad. Sci. USA 100, 11741-11746.
52. Prokai, L., Prokai-Tatrai, K., Perjesi, P., Zharikova, A.D., Simpkins, J.W., 2003b. Quinol-based metabolic cycle for estrogens in rat liver microsomes. Drug Metab. Dispos. 31, 701-704.
53. Resnick, S.M., Espeland, M.A., Jaramillo, S.A., Hirsch, C., Stefanick, M.L., Murray, A.M., Ockene, J., Davatzikos, C., 2009. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 72, 135-142.
54. Romer, W., Oettel, M., Droescher, P., Schwarz, S., 1997a. Novel "scavestrogens" and their radical scavenging effects, iron-chelating, and total antioxidative activities: delta 8, 9-dehydro derivatives of 17 alpha-estradiol and 17 beta-estradiol. Steroids 62, 304-310. (Pubitemid 27121558)
55. Romer, W., Oettel, M., Menzenbach, B., Droescher, P., Schwarz, S., 1997b. Novel estrogens and their radical scavenging effects, iron-chelating, and total antioxidative activities: 17 alpha-substituted analogs of delta 9(11)-dehydro-17 beta-estradiol. Steroids 62, 688-694. (Pubitemid 27486116)
56. Roof, R.L., Hall, E.D., 2000a. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J. Neurotrauma 17, 367-388. (Pubitemid 30327300)
57. Roof, R.L., Hall, E.D., 2000b. Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats. J. Neurotrauma 17, 1155-1169.
58. Roth, A., Schaffner, W., Hertel, C., 1999. Phytoestrogen kaempferol (3, 4′, 5, 7-tetrahydroxyflavone) protects PC12 and T47D cells from beta-amyloid-induced toxicity. J. Neurosci. Res. 57, 399-404.
59. Ruiz-Larrea, B., Leal, A.,Martin, C.,Martinez, R., Lacort, M., 1995. Effects of estrogens on the redox chemistry of iron: a possiblemechanism of the antioxidant action of estrogens. Steroids 60, 780-783.
60. Ruiz-Larrea, M.B., Martin, C., Martinez, R., Navarro, R., Lacort, M., Miller, N.J., 2000. Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens. Chem. Phys. Lipids 105, 179-188.
61. Ryan, T.P., Steenwyk, R.C., Pearson, P.G., Petry, T.W., 1993. Inhibition of in vitro lipid peroxidation by 21-aminosteroids. Evidence for differential mechanisms. Biochem. Pharmacol. 46, 877-884.
62. Salpeter, S.R., Walsh, J.M., Greyber, E., Salpeter, E.E., 2006. Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J. Gen. Intern. Med. 21, 363-366.
63. Santizo, R.A., Xu, H.L., Ye, S., Baughman, V.L., Pelligrino, D.A., 2002. Loss of benefit from estrogen replacement therapy in diabetic ovariectomized female rats subjected to transient forebrain ischemia. Brain Res. 956, 86-95. (Pubitemid 35335560)
64. Shelly, W., Draper, M.W., Krishnan, V., Wong, M., Jaffe, R.B., 2008. Selective estrogen receptor modulators: an update on recent clinical findings. Obstet. Gynecol. Surv. 63, 163-181.
65. Shi, J., Bui, J.D., Yang, S.H., He, Z., Lucas, T.H., Buckley, D.L., Blackband, S.J., King, M.A., Day, A.L., Simpkins, J.W., 2001. Estrogens decrease reperfusion-associated cortical ischemic damage: an MRI analysis in a transient focal ischemia model. Stroke 32, 987-992. (Pubitemid 32285172)
66. Shughrue, P.J., Merchenthaler, I., 2003. Estrogen prevents the loss of CA1 hippocampal neurons in gerbils after ischemic injury. Neuroscience 116, 851-861. (Pubitemid 36160578)
67. Simpkins, J.W., Green, P.S., Gridley, K.E., Singh, M., de Fiebre, N.C., Rajakumar, G., 1997a. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am. J. Med. 103, 19S-25S.
68. Simpkins, J.W., Rajakumar, G., Zhang,Y.Q., Simpkins, C.E.,Greenwald, D., Yu, C.J., Bodor, N., Day, A.L., 1997b. Estrogens may reduce mortality and ischemic damage caused bymiddle cerebral artery occlusion in the female rat. J. Neurosurg. 87, 724-730. (Pubitemid 27454591)
69. Simpkins, J.W., Yang, S.H., Liu, R., Perez, E., Cai, Z.Y., Covey, D.F., Green, P.S., 2004. Estrogen-like compounds for ischemic neuroprotection. Stroke 35, 2648-2651. (Pubitemid 39458359)
70. Simpkins, J.W., Wang, J., Wang, X., Perez, E., Prokai, L., Dykens, J.A., 2005. Mitochondria play a central role in estrogen-induced neuroprotection. Curr. Drug Targets CNS Neurol. Disord. 4, 69-83.
71. Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., White III, C.L., 2004. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 63, 287-301.
72. Sudo, S., Wen, T.C., Desaki, J., Matsuda, S., Tanaka, J., Arai, T., Maeda, N., Sakanaka, M., 1997. Beta-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil. Neurosci. Res. 29, 345-354.
73. Teepker, M., Anthes, N., Krieg, J.C., Vedder, H., 2003. 2-OH-estradiol, an endogenous hormone with neuroprotective functions. J. Psychiatr. Res. 37, 517-523.
74. Toung, T.K., Hurn, P.D., Traystman, R.J., Sieber, F.E., 2000. Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus. Stroke 31, 2701-2706.
75. Veiga, S., Garcia-Segura, L.M., Azcoitia, I., 2003. Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromatase. J. Neurobiol. 56, 398-406. (Pubitemid 37010947)
76. Wang, C.N., Chi, C.W., Lin, Y.L., Chen, C.F., Shiao, Y.J., 2001. The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 276, 5287-5295.
77. Yang, S.H., Shi, J., Day, A.L., Simpkins, J.W., 2000. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31, 745-749 discussion 749-50.
78. Zandi, P.P., Carlson, M.C., Plassman, B.L., Welsh-Bohmer, K.A., Mayer, L.S., Steffens, D.C., Breitner, J.C., 2002. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288, 2123-2129. (Pubitemid 35265379)
79. Zhao, L., Chen, S., Brinton, R.D., 2003. An estrogen replacement therapy containing nine synthetic plant-based conjugated estrogens promotes neuronal survival. Exp. Biol. Med. (Maywood) 228, 823-835.